BetterLife Pharma BETRF
OTC BETRF
$0.22 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

BetterLife Pharma (BETRF) Net Shares Issued and Repurchased (2012 - 2019)

BetterLife Pharma (BETRF) posted Net Shares Issued and Repurchased of $6.2 million for Q1 2019, up 290.88% on a QoQ basis from $1.6 million in Q1 2018, and up 290.88% year-over-year from $1.6 million in Q1 2018.

Analysis

BetterLife Pharma (BETRF) Net Shares Issued and Repurchased (2012 - 2019) Analysis & Trends

BetterLife Pharma has reported Net Shares Issued and Repurchased for 4 years, with the latest figure at $6.2 million in Q1 2019.

  • On a quarterly basis, Net Shares Issued and Repurchased rose 290.88% year-over-year to $6.2 million in Q1 2019; TTM through Jan 2019 was $6.2 million, a 290.88% increase from a year earlier, with the FY2019 full-year figure at $6.3 million, up 215.56% from the prior year.
  • Net Shares Issued and Repurchased was $6.2 million for Q1 2019 at BetterLife Pharma, up from $1.6 million in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $6.2 million in Q1 2019, with the low at -$80000.0 in Q1 2016.
  • Average Net Shares Issued and Repurchased over 3 years is $2.6 million, with a median of $1.6 million recorded in 2018.
  • The largest YoY upside for Net Shares Issued and Repurchased was 290.88% in 2019 against a maximum downside of 290.88% in 2019.
  • Over 3 years, Net Shares Issued and Repurchased stood at -$80000.0 in 2016, then jumped by 2075.29% to $1.6 million in 2018, then jumped by 290.88% to $6.2 million in 2019.
  • The last three Net Shares Issued and Repurchased figures came in at $6.2 million (Q1 2019), $1.6 million (Q1 2018), and -$80000.0 (Q1 2016), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 207.01 Bn 193.02 Bn 7.24 Bn -
2 Gilead Sciences 179.98 Bn 176.80 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 131.45 Bn 123.60 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.02 Bn 74.03 Bn 3.93 Bn -
5 Argenx Se 60.35 Bn 55.16 Bn 1.37 Bn -
6 Moderna 53.69 Bn 48.55 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.11 Bn 29.80 Bn 992.69 Mn -
8 Biogen 31.93 Bn 30.64 Bn 1.96 Bn -
9 Roivant Sciences 29.21 Bn 29.21 Bn 1.16 Mn -
10 BetterLife Pharma 31.61 Mn 31.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2019 6.18 Mn
Jan 31, 2018 1.58 Mn
Jan 31, 2016 -80,000.00
Jan 31, 2012 43,736.00